Key Projections of PCR-based Enteric Disease Testing To Boost Your Business Growth

 

Overview:

The PCR-based enteric disease testing method is one of the most popular diagnosis methods used in developed countries. It is considered to be a fast and easy method of disease diagnosis. The recent development in the rapid diagnosis of whole organisms is MALDI-TOF. Moreover, MALDI-TOF does not require the destruction of the infection sample. Further, it can detect several types of bacterial and fungal infections. The PCR-based enteric disease testing market report contains vital information that can help solve business issues and advance the business.

To Get Complete Industry Insights, Grab Sample PDF Copy Here: https://bit.ly/3AqNpyb

Market Drivers:

Increasing prevalence of food and waterborne diseases around the world is expected to propel growth of the global PCR-based enteric disease testing market over the forecast period. As reported by the World Health Organization (WHO) in March 2022, foodborne diseases affect nearly 600 million people worldwide and cause 420, 000 deaths every year around the world. Due to this demand for PCR-based testing for entering diseases is increasing further driving the market growth.

Moreover, growing demand for early diagnosis due to growing enteric disease infection leading severe health issues is also expected to augment growth of the global PCR-based enteric disease testing market over the forecast period. 

Market Restraints:

However, dearth of appropriated regulates to govern pathogen testing in emerging countries is likely to hamper growth of the global PCR-based enteric disease testing market over the forecast period. 

Regional Insights:

North America is projected to witness substantial growth in the global PCR-based enteric disease testing market over the forecast period. This growth is attributed to increase in health awareness among people, presence of major market players in the region.

Furthermore, Asia Pacific is also anticipated to witness high growth in the global PCR-based enteric disease testing market over the forecast period. This is due to increasing cases of enteric diseases as well as growing awareness among people across the region.

Competitive Landscape:

Major players functioning in the global PCR-based enteric disease testing market are DiaSorin Molecular LLC, Bio-Rad Laboratories, Inc., Trinity Biotech, bioMérieux SA, Abbott, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Vela Diagnostics, Meridian Life Science, Inc., and Coris BioConcept among others.

In April 2022, Chinese Center for Disease Control and Prevention announced the evaluation of a duplex droplet digital PCR (ddPCR) assay targeting Shingella ipaH and Salmonella fimY.